Try GOLD - Free
'We want to make a difference to the lives of 50 cr Indians by 2030'
Healthcare Radius
|September 2023
With tech innovations and new and convenient tests being introduced, the diagnostics laboratories market is on the rise with a high, 11 percent growth. We caught up with Dheeraj Jain, CEO, Redcliffe Labs, who offered insights into which way the market is headed. Excerpts of the interview
-

What are the key demand drivers for the labs market in India?
The rising incidence of chronic diseases like diabetes, CVDs, cancer, and respiratory disorders has been driving demand for diagnostic labs. As the Indian population ages and lifestyle factors contribute to the growth of these diseases, there will be a greater need for accurate and timely diagnosis. For example, the increasing prevalence of diabetes has led to a higher demand for diagnostic tests such as blood glucose monitoring, HbAlc testing, and lipid profiling.
Tech advancements have expanded the range of diagnostic tests and improved their accuracy and efficiency. New techniques, such as molecular diagnostics, genetic testing, and advanced imaging modalities, have increased the demand for laboratory services, allowing early detection, personalized medicine, and targeted therapies. The emergence of next-generation sequencing (NGS) has revolutionized genetic testing and opened new avenues for diagnosing genetic disorders and predicting disease risks.
There is a growing emphasis on preventive healthcare and early detection to improve health outcomes and reduce costs. This shift in the approach has led to a high demand for screening tests, wellness panels, and health checkups offered by diagnostic laboratories. Examples include routine screenings for hypertension, cholesterol levels, and cancer biomarkers, as well as preventive tests for infectious diseases like HIV, hepatitis, and sexually transmitted infections.
In addition, the factors such as increasing healthcare expenditure, expanding access to healthcare services, and growing awareness about the importance of regular checkups, contribute to the sustained growth of the diagnostic laboratories market.
This story is from the September 2023 edition of Healthcare Radius.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Healthcare Radius

Healthcare Radius
ASTER DM HEALTHCARE EXPANDS BENGALURU FOOTPRINT WITH RS 580 CRORE HOSPITAL
Aster DM Healthcare has announced an Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.
1 min
September 2025

Healthcare Radius
COULD DONALD TRUMP'S TRADE MOVES HIT INDIA'S PHARMA EXPORTS NEXT?
If tariffs hit, medicines could cost more in the U.S., and India's drug industry could take a hit. For now, it's all talk, but India's pushing for trade deals and new markets to stay strong.
3 mins
September 2025

Healthcare Radius
HCG TREATS 33-YR-OLD PATIENT WITH SCARLESS CANCER SURGERY
HCG Manavata Cancer Centre (HCGMCC) successfully performed a scarless intraoral surgery on a 33-year-old male diagnosed with buccal mucosa (cheek) cancer.
1 min
September 2025

Healthcare Radius
CELCIUS LOGISTICS LAUNCHES PHARMA COLD CHAIN ARM WITH RS 50CR INVESTMENT
Celcius Logistics has announced the launch of Celcius+, a specialised logistics arm dedicated exclusively to the seamless management of the pharmaceutical supply chain.
1 min
September 2025

Healthcare Radius
PFIZER LAUNCHES 20-VALENT PNEUMONIA VACCINE FOR ADULTS IN INDIA
Pfizer announced the launch of its nextgeneration 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITAL APPOINTS DR. SURENDER DABAS TO LEAD ROBOTIC CANCER CARE IN DELHI
Manipal Hospital welcomes one of India's most renowned and celebrated robotic onco-surgeons, Dr. Surender Kumar Dabas, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.
1 min
September 2025

Healthcare Radius
ZYDUS RECEIVES USFDA APPROVAL FOR CONSTIPATION DRUG PRUCALOPRIDE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Ⓡ Tablets, 1mg and 2 mg).
1 min
September 2025

Healthcare Radius
SSI PERFORMS WORLD'S FIRST CARDIAC TELESURGERY ACROSS 10,000 KM
SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex transcontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITALS SIGNS MOU WITH MAHA GOVT TO INVEST RS 700CR IN NEW NAGPUR HOSPITAL
Manipal Hospitals has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to build a state-of-the-art 350-bed multi-speciality Hospital at Nagpur.
1 min
September 2025

Healthcare Radius
INSIDE INDIA'S AMR CHALLENGE: FIXING AWARENESS, DIAGNOSTICS AND HOSPITAL POLICY GAPS
Dr. Narendra Saini of the IMA unpacks India's escalating AMR crisis, highlighting solutions to bridge awareness, diagnostics and policy gaps in the fight against a looming public health threat.
9 mins
September 2025
Translate
Change font size